Transcriptional control of the C3a receptor gene in glial cells: Dependence upon AP-1 but not Ets

Molecular Immunology

Volumn 44, Issue 5, 2007, Pages 703-712

  Martin, Carol B ^a   Ingersoll, Sarah A ^a   Martin, Brian K ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

AP 1; C3a receptor; Complement; Ets; Gene regulation; Rodent

Indexed keywords

COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3A; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETS;

ANIMAL CELL; ARTICLE; ASTROCYTE; BINDING SITE; BONE MARROW CELL; COMPARATIVE STUDY; CONTROLLED STUDY; DNA BINDING; DNA FOOTPRINTING; GLIA CELL; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPORTER GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; ASTROCYTES; CELL LINE; COMPLEMENT C3A; GENE EXPRESSION REGULATION; MACROPHAGE-1 ANTIGEN; MICE; MICROGLIA; PROTO-ONCOGENE PROTEINS C-ETS; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

RODENTIA;

EID: 33748761376     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.04.017     Document Type: Article

References (32)

1. Ames R.S., Lee D., Foley J.J., Jurewicz A.J., Tornetta M.A., Bautsch W., Settmacher B., Klos A., Erhard K.F., Cousins R.D., Sulpizio A.C., Hieble J.P., McCafferty G., Ward K.W., Adams J.L., Bondinell W.E., Underwood D.C., Osborn R.R., Badger A.M., and Sarau H.M. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J. Immunol. 166 (2001) 6341-6348
2. Aschner M., Sonnewald U., and Tan K.H. Astrocyte modulation of neurotoxic injury. Brain Pathol. 12 (2002) 475-481
3. Barnum S.R., and Szalai A.J. Complement as a biomarker in multiple sclerosis. J. Neuropathol. Exp. Neurol. 64 (2005) 741
4. Benard M., Gonzalez B.J., Schouft M.T., Falluel-Morel A., Vaudry D., Chan P., Vaudry H., and Fontaine M. Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation: neuroprotective effect of C5a against apoptotic cell death. J. Biol. Chem. 2 (2004) 2
5. Boos L., Campbell I.L., Ames R., Wetsel R.A., and Barnum S.R. Deletion of the complement anaphylatoxin c3a receptor attenuates, whereas ectopic expression of c3a in the brain exacerbates, experimental autoimmune encephalomyelitis. J. Immunol. 173 (2004) 4708-4714
6. Boos L., Szalai A.J., and Barnum S.R. C3a expressed in the central nervous system protects against LPS-induced shock. Neurosci. Lett. 387 (2005) 68-71
7. Davoust N., Jones J., Stahel P.F., Ames R.S., and Barnum S.R. Receptor for the C3a anaphylatoxin is expressed by neurons and glial cells. Glia 26 (1999) 201-211
8. Fonseca M.I., Kawas C.H., Troncoso J.C., and Tenner A.J. Neuronal localization of C1q in preclinical Alzheimer's disease. Neurobiol. Dis. 15 (2004) 40-46
9. Fonseca M.I., Zhou J., Botto M., and Tenner A.J. Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. J. Neurosci. 24 (2004) 6457-6465
10. Francis K., Lewis B.M., Akatsu H., Monk P.N., Cain S.A., Scanlon M.F., Morgan B.P., Ham J., and Gasque P. Complement C3a receptors in the pituitary gland: a novel pathway by which an innate immune molecule releases hormones involved in the control of inflammation. FASEB J. 17 (2003) 2266-2268 Epub 2003 Oct 16
11. Gasque P., Singhrao S.K., Neal J.W., Wang P., Sayah S., Fontaine M., and Morgan B.P. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis. J. Immunol. 160 (1998) 3543-3554
12. Gerard C., and Gerard N.P. The pro-inflammatory seven-transmembrane segment receptors of the leukocyte. Curr. Opin. Immunol. 6 (1994) 140-145
13. Humbles A.A., Lu B., Nilsson C.A., Lilly C., Israel E., Fujiwara Y., Gerard N.P., and Gerard C. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406 (2000) 998-1001
14. Ischenko A., Sayah S., Patte C., Andreev S., Gasque P., Schouft M.T., Vaudry H., and Fontaine M. Expression of a functional anaphylatoxin C3a receptor by astrocytes. J. Neurochem. 71 (1998) 2487-2496
15. Kildsgaard J., Hollmann T.J., Matthews K.W., Bian K., Murad F., and Wetsel R.A. Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J. Immunol. 165 (2000) 5406-5409
16. Klein M.A., Kaeser P.S., Schwarz P., Weyd H., Xenarios I., Zinkernagel R.M., Carroll M.C., Verbeek J.S., Botto M., Walport M.J., Molina H., Kalinke U., Acha-Orbea H., and Aguzzi A. Complement facilitates early prion pathogenesis. Nat. Med. 7 (2001) 488-492
17. Kovacs G.G., Gasque P., Strobel T., Lindeck-Pozza E., Strohschneider M., Ironside J.W., Budka H., and Guentchev M. Complement activation in human prion disease. Neurobiol. Dis. 15 (2004) 21-28
18. Martin C.B., and Martin B.K. Characterization of the murine C3a receptor enhancer-promoter: expression control by an activator protein 1 sequence and an Ets-like site. J. Immunol. 175 (2005) 3123-3132
19. Sahu A., and Lambris J.D. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol. Rev. 180 (2001) 35-48
20. Sayah S., Ischenko A.M., Zhakhov A., Bonnard A.S., and Fontaine M. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression. J. Neurochem. 72 (1999) 2426-2436
21. Sayah S., Jauneau A.C., Patte C., Tonon M.C., Vaudry H., and Fontaine M. Two different transduction pathways are activated by C3a and C5a anaphylatoxins on astrocytes. Brain Res. Mol. Brain Res. 112 (2003) 53-60
22. Schaefer M., Konrad S., Thalmann J., Rheinheimer C., Johswich K., Sohns B., and Klos A. The transcription factors AP-1 and Ets are regulators of C3a receptor expression. J. Biol. Chem. 280 (2005) 42113-42123 Epub 2005 Oct 27
23. Singhrao S.K., Neal J.W., Morgan B.P., and Gasque P. Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease. Exp. Neurol. 159 (1999) 362-376
24. Smith M.E. Phagocytosis of myelin in demyelinative disease: a review. Neurochem. Res. 24 (1999) 261-268
25. Smith M.E. Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE. Microsc. Res. Tech. 54 (2001) 81-94
26. Soos J.M., Morrow J., Ashley T.A., Szente B.E., Bikoff E.K., and Zamvil S.S. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells. J. Immunol. 161 (1998) 5959-5966
27. Sospedra M., and Martin R. Immunology of Multiple Sclerosis. Annu. Rev. Immunol. 27 (2004) 27
28. Sriram S., and Rodriguez M. Indictment of the microglia as the villain in multiple sclerosis. Neurology 48 (1997) 464-470
29. Strey C.W., Markiewski M., Mastellos D., Tudoran R., Spruce L.A., Greenbaum L.E., and Lambris J.D. The proinflammatory mediators C3a and C5a are essential for liver regeneration. J. Exp. Med. 198 (2003) 913-923
30. Van Beek J., Bernaudin M., Petit E., Gasque P., Nouvelot A., MacKenzie E.T., and Fontaine M. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse. Exp. Neurol. 161 (2000) 373-382
31. van Beek J., Nicole O., Ali C., Ischenko A., MacKenzie E.T., Buisson A., and Fontaine M. Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death. Neuroreport 12 (2001) 289-293
32. Warshawsky D., and Miller L. Mapping protein-DNA interactions using in vivo footprinting. Meth. Mol. Biol. 127 (1999) 199-212